We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Polycarbonate Blend Ideal for Medical and Diagnostic Equipment

By LabMedica International staff writers
Posted on 01 Apr 2010
A new polycarbonate/acrylonitrile-butadiene-styrene (PC/ABS) blend is suitable for applications in medical technology, including the manufacture of diagnostic equipment.

In addition to its excellent impact resistance, stiffness, dimensional and color stability, heat resistance and processing properties, the Bayblend M850XF product grade satisfies the biocompatibility requirements of International Organization for Standardization (ISO) 10933 Part 1 as modified by the U.S. More...
Federal Drug Administration (FDA; Silver Springs, MD, USA). The new Bayblend grade can be sterilized by ethylene oxide (EtO), gamma radiation, or electron rays.

Bayer MaterialScience (Leverkusen, Germany) developed Bayblend M850XF, expanding its portfolio of PC/ABS. The product is particularly suitable for injection molding thin-walled components.

"Bayblend M850XF offers the balanced combination of processability and physical properties required for components used in medical and diagnostic equipment," explained Markus Krieter, an expert for applications in medical technology at Bayer MaterialScience.

Bayer MaterialScience is focused on the manufacture of high-tech polymer materials. It is a Bayer Group company.

Related Links:

U.S. Federal Drug Administration
Bayer MaterialScience



Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit
New
Pipette
Accumax Smart Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.